Chimeric Antigen Receptor T-Cell Therapy NewsLatest News On Chimeric Antigen Receptor T-Cell Therapy CAR T Excels in Second-Line Lymphoma Care8/21/2025 6:53 PM Cilta-cel CAR T: Myeloma ‘Cure’ and Conjecture7/28/2025 3:44 PM Novel Agents Transform Double-Refractory Chronic Lymphocytic Leukemia Care7/23/2025 5:56 AM How Myeloma Plays Hide and Seek With CAR T Cells7/23/2025 3:03 AM Drug Combo Outpaces Standard Chemo in R/R LBCL7/8/2025 11:48 PM Radiation Bridging in CAR T: Where Are We Now?7/4/2025 6:24 AM FDA Drops REMS Programs for Some CAR-Ts6/30/2025 5:58 PM Clinical Advances in Multiple Myeloma From ASCO 20256/23/2025 5:28 PM Lymphoma Highlights From ASCO 20256/23/2025 1:59 PM DLBCL: Tumor Cell Signatures Predict CAR-T Success6/20/2025 6:34 AM
